06/09/2025
5:05 AM | Cara Therapeutics (Filer)
Tvardi Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2025
8:04 AM | DePinho Ronald A (Filed by)
Cara Therapeutics (Subject)
Tvardi Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G | |
05/27/2025
7:09 AM | Cara Therapeutics (Filer)
Tvardi Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
3:20 PM | Cara Therapeutics (Filer)
Tvardi Therapeutics, Inc. (Filer)
| Form 8-K/A | |
05/02/2025
5:12 PM | Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
Wirk Shaheen (Reporting)
| Form 4/A | |
05/02/2025
5:19 PM | HALL WALLACE L JR (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4/A | |
05/02/2025
3:21 PM | Cara Therapeutics (Subject)
Tvardi Therapeutics, Inc. (Subject)
Tweardy David John (Filed by)
| Form SCHEDULE 13G | |
04/22/2025
1:26 PM | Solas Tvardi Sidecar LLC (Filed by)
Cara Therapeutics (Subject)
Tvardi Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G | |
04/21/2025
4:15 PM | HALL WALLACE L JR (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Shah Sujal (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Smith Cynthia (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CARA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/21/2025
4:15 PM | Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
WYZGA MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
Wirk Shaheen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Shiff Susan Ph.D. (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Alibhai Imran Nizamudin (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Kauh John Saewook M.D. (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Conn Avi Daniel (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Chen Yixin (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | O'Brien Stephen Paul (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Larson Jeffrey Leroy (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Alibhai Imran Nizamudin (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Conn Avi Daniel (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Larson Jeffrey Leroy (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Shah Sujal (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
Wirk Shaheen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Chen Yixin (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
WYZGA MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Kauh John Saewook M.D. (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | HALL WALLACE L JR (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | O'Brien Stephen Paul (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:19 PM | Shah Sujal (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:22 PM | Conn Avi Daniel (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:24 PM | Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
Wirk Shaheen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:26 PM | HALL WALLACE L JR (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:28 PM | Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
WYZGA MICHAEL S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:30 PM | O'Brien Stephen Paul (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:05 PM | Larson Jeffrey Leroy (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:08 PM | Chen Yixin (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:11 PM | Smith Cynthia (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:13 PM | Alibhai Imran Nizamudin (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:16 PM | Kauh John Saewook M.D. (Reporting)
Cara Therapeutics (Issuer)
Tvardi Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Trump wipes out trillions overnight… (Ad) Is there anybody more powerful than Donald Trump right now?
In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones…
Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move. Whether you take some of that wealth for yourself depends on if you watch this controversial exposé |
04/11/2025
3:16 PM | Cara Therapeutics (Filer)
Cara Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
3:30 PM | Cara Therapeutics (Filer)
Cara Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
3:30 PM | Cara Therapeutics (Filer)
Cara Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
3:30 PM | Cara Therapeutics (Subject)
Cara Therapeutics, Inc. (Subject)
| Form 425 | |
02/17/2025
11:15 PM | Cara Therapeutics (Filer)
Cara Therapeutics, Inc. (Filer)
| Form EFFECT | |
02/14/2025
4:13 PM | Cara Therapeutics (Filer)
Cara Therapeutics, Inc. (Filer)
| Form 424B3 | |
02/14/2025
5:01 AM | Cara Therapeutics (Filer)
Cara Therapeutics, Inc. (Filer)
| Form S-4/A | |
02/06/2025
6:15 PM | Cara Therapeutics (Issuer)
Cara Therapeutics, Inc. (Issuer)
Posner Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:19 AM | Cara Therapeutics (Filer)
Cara Therapeutics, Inc. (Filer)
| Form S-4/A | |
01/21/2025
7:50 AM | Cara Therapeutics (Filer)
Cara Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2025
7:53 AM | Cara Therapeutics (Subject)
Cara Therapeutics, Inc. (Subject)
| Form 425 | |
01/17/2025
3:43 PM | Cara Therapeutics (Filer)
Cara Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2025
3:44 PM | Cara Therapeutics (Subject)
Cara Therapeutics, Inc. (Subject)
| Form 425 | |
12/30/2024
3:02 PM | Cara Therapeutics (Subject)
Cara Therapeutics, Inc. (Subject)
| Form 425 | |
12/30/2024
3:01 PM | Cara Therapeutics (Filer)
Cara Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
4:10 PM | Cara Therapeutics (Subject)
Cara Therapeutics, Inc. (Subject)
Vifor Ltd (0001675217) (Filed by)
| Form SCHEDULE 13D/A | |
12/18/2024
3:26 PM | Cara Therapeutics (Filer)
Cara Therapeutics, Inc. (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
12/18/2024
6:23 AM | Cara Therapeutics (Filer)
Cara Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
6:25 AM | Cara Therapeutics (Subject)
Cara Therapeutics, Inc. (Subject)
| Form 425 | |
11/22/2024
3:09 PM | Cara Therapeutics (Filer)
Cara Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:51 PM | Cara Therapeutics (Issuer)
Cara Therapeutics, Inc. (Issuer)
Posner Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
3:21 PM | Cara Therapeutics (Subject)
Cara Therapeutics, Inc. (Subject)
Vifor Ltd (0001675217) (Filed by)
| Form SC 13D | |
08/01/2024
3:15 PM | Cara Therapeutics (Filer)
Cara Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Cara Therapeutics (Subject)
Cara Therapeutics, Inc. (Subject)
| Form SC 13G/A | |
Buy CARA Stock Free CARA Stock Alerts